External review

An independent reviewer examines an eligible plan decision

The CMS Uniform Glossary describes an appeal as a request to review a denied benefit or payment. External review moves an eligible issue to an independent reviewer that is not part of the plan.

External review often concerns denials involving medical judgment, medical necessity, appropriateness, setting, level of care, effectiveness, experimental or investigational treatment, or rescission. The exact eligible issues come from the governing process.

Internal appeal commonly comes first

The HealthCare.gov internal appeals guide explains that a person can generally seek external review after the plan upholds a denial. In urgent situations, internal and external requests may proceed at the same time under applicable rules.

Medicaid fair hearings, Medicare appeals, employer-plan procedures, state external review, Marketplace products, and other programs can use different names and stages. Follow the notice instead of assuming the HealthCare.gov sequence applies.

The decision notice supplies the route

Record:

• member, plan, product, denial, date, and affected service
• internal appeal history and final determination
• issue eligible for external review and cited authority
• filing deadline, submission route, fee when applicable, and required form
• authorized representative and appointment evidence
• clinical record, payer criteria, plan terms, and documents already reviewed
• standard or expedited request and supporting urgency evidence
• receipt, reviewer, communications, decision, and implementation status

Keep the clinical recommendation separate from the plan decision. A qualified clinician authors clinical evidence within scope. Operations can assemble the authorized record and track deadlines. Legal conclusions and representative authority require the responsible qualified role.

Federal consumer guidance has defined timing and current caveats

The HealthCare.gov external review guide describes a four-month filing period for the process it covers, a standard decision as soon as possible and no later than 45 days, and an expedited decision as soon as possible and no later than 72 hours. State processes may provide different or additional protections.

That page also states that, beginning July 1, 2026, the HHS-administered Federal External Review Process is temporarily unavailable for specified plans and jurisdictions and directs people to current plan notices. This is a time-sensitive operational warning. Check the page and the denial notice immediately before filing.

A remittance reason may start the research

The manifest-provided CMS remittance guidance explains Medicare ERA and paper-remittance information. A remittance can reveal the claim outcome and reason, while external-review eligibility usually comes from the plan's final denial and appeal notice.

Separate a claim rejection, corrected-claim issue, contractual payment dispute, internal appeal, grievance, and eligible external review. Sending the wrong dispute through an independent-review route can waste a filing window.

External review is separate from emergency response

An urgent external review remains an insurance process. Immediate danger or a medical emergency calls for local emergency action. A qualified clinician determines care or safe transition within available authority while the coverage dispute proceeds.

Families should receive accessible updates about what was filed, which decision is pending, current coverage uncertainty, and any financial assumptions. Avoid promises about outcome or payment.

Ask the plan or reviewer who may submit later evidence, how it will be shared with the parties, and when the record closes. Keep copies of every document and transmission receipt. If a deadline or route is unclear, seek help from the plan, state consumer-assistance program, regulator, benefits adviser, or qualified counsel before the filing period expires.

A fictional external-review file

Elias is a fictional parent whose plan upheld an ABA coverage denial after internal appeal. The final notice identifies an external-review route and lists 11 required evidence items.

Nine items are ready. The authorized-representative form and the plan's complete final adverse determination are missing. File readiness is 9 of 11 items, or 81.8%. Both open items remain in the denominator with owners and due dates.

After receipt, the team records the reviewer, deadline, later information requests, decision, and plan implementation. The readiness percentage predicts neither acceptance nor reversal.

Measure route and decision separately

Useful measures include eligible final denials identified; requests filed by deadline; receipt confirmed; complete files; expedited classifications; decisions by due date; overturned, partially overturned, and upheld decisions; and implementation completed.

Use one mature cohort for outcomes. Segment by payer, product, jurisdiction, issue, review route, and urgency. Keep requested service, clinical recommendation, coverage decision, external decision, delivered care, claim, and payment separate.

Check the final internal denial, EOB, plan documents, current federal page, state regulator, and consumer-assistance route immediately before filing. Record eligibility, ordinary or expedited status, deadline, any current extension, submission channel, receipt, independent reviewer, clinical record, and determination. A route or deadline copied from another product or state can forfeit review.